Skip to content
10-K

Annual Report

LENZ THERAPEUTICS, INC. LENZ

0001815776-26-000011

← back to feed
Filed
Mar 24, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 18, 2026 31.35M sh
Shares Diluted FY 2025 · Dec 31, 2025 28.81M sh
Shares Diluted FY 2025 · Dec 31, 2024 21.28M sh
Capex FY 2025 · Dec 31, 2025 $827K
Capex FY 2025 · Dec 31, 2024 $468K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$69.17M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$59.39M
Cash And Equivalents FY 2025 · Dec 31, 2025 $25.18M
Cash And Equivalents FY 2025 · Dec 31, 2024 $20.16M
Stockholders Equity FY 2025 · Dec 31, 2025 $284.34M
Stockholders Equity FY 2025 · Dec 31, 2024 $204.08M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$92.71M
Current Liabilities FY 2025 · Dec 31, 2025 $21.19M
Current Liabilities FY 2025 · Dec 31, 2024 $10.41M
Total Liabilities FY 2025 · Dec 31, 2025 $21.54M
Total Liabilities FY 2025 · Dec 31, 2024 $11.22M
Current Assets FY 2025 · Dec 31, 2025 $301.41M
Current Assets FY 2025 · Dec 31, 2024 $211.92M
Total Assets FY 2025 · Dec 31, 2025 $305.88M
Total Assets FY 2025 · Dec 31, 2024 $215.3M
Eps Diluted FY 2025 · Dec 31, 2025 −$2.85
Eps Diluted FY 2025 · Dec 31, 2024 −$2.34
Eps Basic FY 2025 · Dec 31, 2025 −$2.85
Eps Basic FY 2025 · Dec 31, 2024 −$2.34
Sga Expense FY 2025 · Dec 31, 2025 $91.14M
Sga Expense FY 2025 · Dec 31, 2024 $28.81M
Rd Expense FY 2025 · Dec 31, 2025 $18.67M
Rd Expense FY 2025 · Dec 31, 2024 $29.8M
Net Income FY 2025 · Dec 31, 2025 −$82.13M
Net Income FY 2025 · Dec 31, 2024 −$49.77M
Operating Income FY 2025 · Dec 31, 2025 −$91.14M
Operating Income FY 2025 · Dec 31, 2024 −$58.61M
Cost Of Revenue FY 2025 · Dec 31, 2025 $418K
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2025 $19.09M
Revenue FY 2025 · Dec 31, 2024 $0